Search

Home > Gastroenterology > Subcutaneous Golimumab Induces and Maintains Clinical Response and Remission in Patients with Moderate-to-Severe Ulcerative Colitis
Podcast: Gastroenterology
Episode:

Subcutaneous Golimumab Induces and Maintains Clinical Response and Remission in Patients with Moderate-to-Severe Ulcerative Colitis
Category: Science & Medicine
Duration: 00:18:27
Publish Date: 2014-01-31 17:32:51
Description: Two studies in the January issue of Gastroenterology show that subcutaneous golimumab induces and maintains clinical response and remission in patients with moderate-to-severe ulcerative colitis; Dr. Kuemmerle speaks to Dr. Brian G. Feagan
Total Play: 0

Some more Podcasts by AGA

70+ Episodes
Clinical Gas .. 20+     4